Agamree

vamorolone

Approval

ApplicationNDA 215239
Approval dateOct 26, 2023
Approval year2023
SponsorCatalyst Pharms

FDA-approved use

To treat Duchenne muscular dystrophy

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Agamree: